DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Lac-Leamy

2026 年 10 月 26 日 7:30 上午 - 2026 年 10 月 27 日 4:00 下午

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 7, Track A: Optimizing Canadian Submissions: Risk-Based Framework Approach for Package Inserts, XML PM Authoring and CMC Trends

Session Chair(s)

Adesola  Adeyemi

Adesola Adeyemi

Regulatory Affairs Project Manager, Bayer Inc., Canada

This session will focus on advancing regulatory decision-making through integrated, structured approaches to labeling, XML PM authoring, and CMC submission quality. It will explore how a risk-based regulatory process is improving consistency and transparency in package insert decisions in order to equip participants with a better understanding of how these principles can be applied. Practical strategies to implement compliant, efficient XML Product Monograph authoring workflows will be discussed. Participants will also gain insights into how structured CMC authoring reduces variability, mitigates supply risk, and supports more robust regulatory outcomes in an increasingly complex landscape. Attendees will leave with actionable frameworks, practical strategies, and a clearer understanding of how to strengthen submission quality, streamline processes, and reduce regulatory delays through structured, risk-based approaches.

Learning Objective :
  • Understand Health Canada’s structured, risk-based process guiding recommendations on package insert inclusion or omission
  • Understand the steps for XML PM authoring, identify common challenges and apply practical strategies and tools to streamline XML PM creation, validation and publishing
  • Identify and address CMC submission quality gaps that drive delays and supply risk and recognize current and emerging CMC regulatory trends

Speaker(s)

Amanda  Starr, PhD

Advancing a Risk-Based Framework for Package Insert Decision-Making Across Directorates

Amanda Starr, PhD

Scientific Evaluator - Pharmaceutical Drugs Directorate, Health Canada, Canada

Kenneth  Gutierrez, MBA

CMC Submission Quality as Supply Risk: How Structured Authoring Reduces Variability and Regulatory Delay

Kenneth Gutierrez, MBA

Director of Product, Docuvera, United States

Melissa  Bieman

XML PM Authoring: Practical Strategies, Challenges, and Insights

Melissa Bieman

Manager, Regulatory Affairs, Intrinsik Corp., Canada

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。